97 related articles for article (PubMed ID: 36512682)
1. Case Series: Synergistic Effect of Gabapentin and Adjuvant Pregabalin in Neuropathic Pain.
Chow SP; Stevens S; Tran S; Donelenko S
J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):106-109. PubMed ID: 36512682
[TBL] [Abstract][Full Text] [Related]
2. Use of kersetin and fisetin flavonoids in combination with pregabalin and gabapentin in the treatment of neuropathic pain.
Karabacak E; Eken H; Dallali I; Arslan R
J Pharm Pharmacol; 2024 Jul; 76(7):824-833. PubMed ID: 38588462
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin improves neuropathic pain in Minamata disease model rats.
Fujimura M
Environ Health Prev Med; 2024; 29():31. PubMed ID: 38825526
[TBL] [Abstract][Full Text] [Related]
4. Neuropathic pain.
Colloca L; Ludman T; Bouhassira D; Baron R; Dickenson AH; Yarnitsky D; Freeman R; Truini A; Attal N; Finnerup NB; Eccleston C; Kalso E; Bennett DL; Dworkin RH; Raja SN
Nat Rev Dis Primers; 2017 Feb; 3():17002. PubMed ID: 28205574
[TBL] [Abstract][Full Text] [Related]
5. Gabapentinoids Suppress Lipopolysaccharide-Induced Interleukin-6 Production in Primary Cell Cultures of the Rat Spinal Dorsal Horn.
Nürnberger F; Rummel C; Ott D; Gerstberger R; Schmidt MJ; Roth J; Leisengang S
Neuroimmunomodulation; 2023; 30(1):1-14. PubMed ID: 35843206
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of gabapentin and pregabalin on wound healing in rats.
Sarıtaş TB; Korkmaz M; Sevimli A; Sarıtaş ZK
Int Wound J; 2016 Oct; 13(5):748-53. PubMed ID: 25348659
[TBL] [Abstract][Full Text] [Related]
7. The synergistic anti-nociceptive effects of nefopam and gabapentinoids in inflammatory, osteoarthritis, and neuropathic pain mouse models.
Xiao XY; Chen YM; Zhu J; Yin MY; Huang CN; Qin HM; Liu SX; Xiao Y; Fang HW; Zhuang T; Chen Y
Eur J Pharmacol; 2024 Aug; 977():176738. PubMed ID: 38876275
[TBL] [Abstract][Full Text] [Related]
8. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.
Straube S; Derry S; McQuay HJ; Moore RA
Br J Clin Pharmacol; 2008 Aug; 66(2):266-75. PubMed ID: 18489611
[TBL] [Abstract][Full Text] [Related]
9. A next generation peripherally restricted Cavα2δ-1 ligand with inhibitory action on Cav2.2 channels and utility in neuropathic pain.
Kricek F; Ruf C; Meghani P; Souza IA; Gandini MA; Zamponi GW; Skouteris G
Biomed Pharmacother; 2024 May; 174():116472. PubMed ID: 38531121
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin and (S)-pregabalin decrease intracellular D-serine concentrations in PC-12 cells.
Singh NS; Paul RK; Torjman MC; Wainer IW
Neurosci Lett; 2013 Feb; 535():90-4. PubMed ID: 23274708
[TBL] [Abstract][Full Text] [Related]
11. Misuse of gabapentinoids (pregabalin and gabapentin) in patients with neuropathic pain related to spinal cord injury.
Polat CS; Konak HE; Akıncı MG; Onat SS; Altas EU
J Spinal Cord Med; 2023 Sep; 46(5):859-864. PubMed ID: 35108174
[TBL] [Abstract][Full Text] [Related]
12. Gabapentinoids and lactation: Review of the literature.
Özalp Horsanalı B; Yımaz H; Uyar M; Eyigör C
Agri; 2024 Jan; 36(1):64-67. PubMed ID: 38239114
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effectiveness of antidepressant therapy adjuvant to gabapentin and pregabalin for treatment of SCI-related neuropathic pain.
McKinley EC; Richardson EJ; McGwin G; Zhang J
J Spinal Cord Med; 2018 Nov; 41(6):637-644. PubMed ID: 29319453
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin inhibits purinergic P2Y
Song S; Wang Q; Qu Y; Gao W; Li D; Xu X; Yue S
Eur J Pharmacol; 2023 Dec; 960():176140. PubMed ID: 37925132
[TBL] [Abstract][Full Text] [Related]
15. Development of a PET radioligand for α2δ-1 subunit of calcium channels for imaging neuropathic pain.
Zhou YP; Sun Y; Takahashi K; Belov V; Andrews N; Woolf CJ; Brugarolas P
Eur J Med Chem; 2022 Nov; 242():114688. PubMed ID: 36031695
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.
Eroglu C; Allen NJ; Susman MW; O'Rourke NA; Park CY; Ozkan E; Chakraborty C; Mulinyawe SB; Annis DS; Huberman AD; Green EM; Lawler J; Dolmetsch R; Garcia KC; Smith SJ; Luo ZD; Rosenthal A; Mosher DF; Barres BA
Cell; 2009 Oct; 139(2):380-92. PubMed ID: 19818485
[TBL] [Abstract][Full Text] [Related]
17. The effect of gabapentin and pregabalin on agitation in dementia: Case series of ten patients.
Kandemir Yilmaz M
Rev Neurol (Paris); 2024 Jun; 180(6):559-563. PubMed ID: 38311525
[No Abstract] [Full Text] [Related]
18. Pregabalin versus Gabapentin Efficacy in the Management of Neuropathic Pain Associated with Failed Back Surgery Syndrome.
Al-Ameri LT; Shukri ME; Hameed EK; Marzook AA
J Korean Neurosurg Soc; 2024 Mar; 67(2):202-208. PubMed ID: 37709550
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin produces similar effects as gabapentin for preanesthetic sedation in cats.
Madan RD; Cenani A; Montgomery E; Azevedo T; Vernau KM; Brosnan RJ
J Am Vet Med Assoc; 2024 Mar; 262(3):359-363. PubMed ID: 38134455
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
Knowles GM; LaFleur GE; Churchwell MD
J Pharm Technol; 2024 Feb; 40(1):30-36. PubMed ID: 38318261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
